Angarkay Medi Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.25 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.60 Cr
About Angarkay Medi Science
Angarkay Medi Science Private Limited (AMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2018 (Six years and 11 months 11 days old ). Its registered office is in Baran, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.25 M.
The company currently has active open charges totaling ₹10.60 Cr.
Pavitra Gurjar, Sarla Jain, Chetan Kumra, and Three other members serve as directors at the Company.
Company Details
-
Location
Baran, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85200RJ2018PTC060330
-
Company No.
060330
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Angarkay Medi Science?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pavitra Gurjar
|
Director | 24-Feb-2018 | Current |
|
Sarla Jain
|
Director | 24-Feb-2018 | Current |
|
Chetan Kumra
|
Director | 05-May-2018 | Current |
|
Anjna Agrawal
|
Director | 05-May-2018 | Current |
|
Shubhanshu Jain
|
Director | 12-Feb-2023 | Current |
|
Priyadarshini
|
Director | 07-Jul-2023 | Current |
Financial Performance of Angarkay Medi Science.
Angarkay Medi Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angarkay Medi Science?
Unlock access to Angarkay Medi Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Anaxee Healthcare Private LimitedPavitra Gurjar is a mutual person
Charges (Loans)
₹106.05 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.98 Cr
- Axis Bank Limited : 4.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2024 | Others | ₹2.50 M | Open |
| 22 Mar 2024 | Others | ₹3.45 M | Open |
| 29 Feb 2024 | Others | ₹3.50 M | Open |
| 27 Dec 2023 | Others | ₹4.46 M | Open |
| 26 Dec 2023 | Others | ₹2.51 Cr | Open |
How Many Employees Work at Angarkay Medi Science?
Angarkay Medi Science has a workforce of 29 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angarkay Medi Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angarkay Medi Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.